Friday 6 November 2026 Export VCYT’s income statement to Excel — free account

Veracyte, Inc.

VCYT Healthcare Diagnostics & Research

Veracyte, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $517.1 million, up 16.0% from fiscal 2024.

Revenue: +15.1%
EPS: +62.5%
Free cash flow: −9.63%

Quarter to September 2026, against a year earlier

24.18 0.18 +0.75%

Follow VCYT

Alert me

Market cap: $1.9B
P/E: 15.2×
Fwd P/E: 45.2×
Dividend yield: —
F-score: 8/9
Altman Z: 21.08
Beneish M: −2.66
Dividend safety: n/a

Overview

Veracyte, Inc. (VCYT) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Veracyte, Inc. (VCYT) trades at a P/B ratio of 1.4×. Over the past ten years it has ranged from 1.0× (May 2022) to 16.8× (August 2018); the current reading is higher than 3% of that period. That is below the Diagnostics & Research industry median of 3.4× and below the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/VCYT/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Veracyte, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/VCYT/metrics/pb-ratio">Veracyte, Inc. (VCYT) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	2.5×	(1.91%)
FY2024	2.6×	35.10%
FY2023	1.9×	26.49%
FY2022	1.5×	(40.91%)
FY2021	2.6×	(58.76%)
FY2020	6.2×	14.98%
FY2019	5.4×	(7.87%)
FY2018	5.8×	(4.66%)
FY2017	6.1×	61.23%
FY2016	3.8×	4.02%

Period	P/B ratio	Change
Sep 2026	2.6×	(23.56%)
Jun 2026	3.4×	77.52%
Mar 2026	1.9×	(24.57%)
Dec 2025	2.5×	17.56%
43 more quarters	Free account

Against its own ten years

Low 1.0× High 16.8×

Ten-year median 3.4×

Current reading's percentile 4

Company	P/B ratio
VCYT Veracyte, Inc.	1.4×
GRAL GRAIL, Inc. compare	2.4×
NEO NeoGenomics, Inc. compare	2.7×
RDNT RadNet, Inc. compare	4.4×
SHC Sotera Health Company compare	6.2×
WGS GeneDx Holdings Corp. compare	7.9×
CDNA CareDx, Inc. compare	8.6×
BLLN BillionToOne, Inc. compare	9.9×
ADPT Adaptive Biotechnologies Corporation compare	23.5×
Diagnostics & Research industry median	3.4×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Veracyte, Inc. (VCYT) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on VCYT

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on VCYT

Stockrow Weekly